These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16871591)

  • 1. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
    Uchinami H; Seki E; Brenner DA; D'Armiento J
    Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
    Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
    PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and
    Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
    Am J Physiol Gastrointest Liver Physiol; 2023 Dec; 325(6):G608-G621. PubMed ID: 37873581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
    Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
    Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
    Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
    Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
    Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
    Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
    Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 participates in the progression from liver injury to fibrosis.
    Gieling RG; Wallace K; Han YP
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1324-31. PubMed ID: 19342509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
    Villar-Lorenzo A; Rada P; Rey E; Marañón P; Arroba AI; Santamaría B; Sáiz J; Rupérez FJ; Barbas C; García-Monzón C; Valverde ÁM; González-Rodríguez Á
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31262748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.
    Onozuka I; Kakinuma S; Kamiya A; Miyoshi M; Sakamoto N; Kiyohashi K; Watanabe T; Funaoka Y; Ueyama M; Nakagawa M; Koshikawa N; Seiki M; Nakauchi H; Watanabe M
    Biochem Biophys Res Commun; 2011 Mar; 406(1):134-40. PubMed ID: 21300023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Effects of Ger-Gen-Chyn-Lian-Tang on Cholestatic Liver Fibrosis in Bile Duct Ligation-Challenged Mice.
    Chang ZY; Chen CC; Liu HM; Yeh YC; Lin TY; Lee TY; Huang TH
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.
    Chen P; Kakan X; Wang S; Dong W; Jia A; Cai C; Zhang J
    Exp Toxicol Pathol; 2013 May; 65(4):427-32. PubMed ID: 22261359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats.
    El-Swefy S; Hassanen SI
    Ann Hepatol; 2009; 8(1):41-9. PubMed ID: 19221533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
    Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
    Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
    Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
    Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.